At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
Unlock the market timeline & signal feed
2,136 signals in the last 90 days.
The order this company entered each market — oldest to newest
The Sequence podcast EP1: Inside the global genomics leader
The Sequence podcast EP1: Inside the global genomics leader
Sign up to see the full signal feed
How Illumina's international expansion compares to its competitors
IlluminaYouBars show relative size across the companies compared.
5 metrics| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 IlluminaYou | 32 | 0 | -79% | 2.1k | 36 |
Scaling fast — 146 roles opened in the last 90 days, up 56% vs the prior period. Engineering-led and concentrated in Singapore.
Mexico · yesterday
CRM Senior Business Systems Analyst
Greater Bengaluru Area · yesterday
Staff PLM Ops Analyst
Singapore · yesterday
Logistics Coordinator 2
51 technologies detected across the stack.
299 active campaigns across 201 markets.
Active7 mentions in the last 90 days.
Illumina launches MiSeq i100 Series-CN in China, manufactured locally with global quality standards, supporting research, public health, and biopharmaceutical sequencing applications with faster delivery and service.
First full week of August features major earnings reports from AI, semiconductor, healthcare, energy, consumer, software, fintech, travel, and quantum computing companies, with focus on Palantir and other market heavyweights.
Illumina launched a mobile bioinformatics solution powered by DRAGEN for on-site genomic analysis, addressing data localization compliance and deployment efficiency challenges in large-scale genomic research and clinical trials.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Illumina's business, markets, and growth signals.
“We reach accounts the week they land in-market — not the quarter after.”
Book a walkthrough of the movement map with our team.
Pubrio turns expansion signals across 200+ markets into one live graph, so revenue teams see which companies are entering new markets, and act on the timing.
© 2026 Pubrio. All rights reserved.
